文献速递银屑病与炎症性皮肤病

银屑病患者的疲劳:一项对照研究

Fatigue in psoriasis: a controlled study.
PubMed 文献 · Br J Dermatol · 2017-06-24

本研究纳入84例慢性斑块状银屑病患者和84名年龄性别匹配的健康对照,用三种通用疲劳量表评估疲劳严重程度。

要点

  • 约50%银屑病患者存在临床重要疲劳,显著高于健康对照。
  • 疲劳严重程度与吸烟、疼痛和抑郁相关,与PASI评分无关。
  • 评估银屑病疲劳可用fVAS、FSS和SF-36活力量表。

核心结论

  • 近50%的银屑病患者存在显著疲劳,疲劳严重程度与吸烟、疼痛和抑郁相关,但与银屑病严重程度无关。

研究设计与样本

  • 对照研究,纳入84例慢性斑块状银屑病患者和84名年龄、性别匹配的健康对照。
  • 使用fVAS、FSS和SF-36活力量表评估疲劳严重程度。
  • 疾病活动度用PASI评估,生活质量影响用DLQI评估。

主要发现

  • 患者与对照的中位fVAS评分分别为51(IQR 21-67)和11(IQR 3-20)。
  • 患者与对照的中位SF-36活力评分分别为43(IQR 25-85)和73(IQR 65-85)。
  • 单变量分析中疲劳与DLQI评分相关、与PASI评分无关,但多变量分析中均不显著。

关键数值与推荐

  • 临床重要疲劳的截断值定义为:FSS ≥ 4,fVAS ≥ 50,SF-36活力量表 ≤ 35。

临床怎么用

  • 银屑病患者应常规关注疲劳症状,尤其对吸烟、疼痛或抑郁患者。
  • 疲劳评估可独立于银屑病皮损严重程度进行。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Fatigue is associated with various chronic inflammatory diseases, but few studies have focused on its occurrence in psoriasis. OBJECTIVES: To describe fatigue prevalence and degree among patients with chronic plaque psoriasis vs. age- and sex-matched healthy subjects, and to examine how fatigue is influenced by essential clinical and demographic factors. METHODS: In 84 patients and 84 healthy subjects, fatigue severity was assessed using three different generic fatigue instruments: the fatigue Visual Analogue Scale (fVAS), the Fatigue Severity Scale (FSS) and the Short Form 36 (SF-36) Vitality scale. Cut-off scores for clinically important fatigue were defined as ≥ 4 for FSS, ≥ 50 for fVAS and ≤ 35 for the SF-36 Vitality scale. Disease activity was evaluated using the Psoriasis Area and Severity Index (PASI), and the impact on quality of life with the Dermatology Life Quality Index (DLQI). RESULTS: Patients and healthy control subjects, respectively, showed median fVAS scores of 51 [interquartile range (IQR) 21-67] and 11 (IQR 3-20); FSS scores of 4 (IQR 2·5-5·3) and 1·6 (IQR 1·1-2·2); and SF-36 Vitality scores of 43 (IQR 25-85) and 73 (IQR 65-85). The rates of clinically important fatigue among patients vs. healthy controls, respectively, were 51% vs. 4% (fVAS); 52% vs. 4% (FSS); and 42% vs. 2% (SF-36 Vitality) (P < 0·001 for all differences). Fatigue was associated with DLQI scores, but not PASI scores, in univariate analysis but not in multivariate analysis. CONCLUSIONS: Nearly 50% of patients with psoriasis suffered from substantial fatigue. Fatigue severity was associated with smoking, pain and depression, but not with psoriasis severity.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Skoie IM, Dalen I, Ternowitz T, et al. Fatigue in psoriasis: a controlled study. Br J Dermatol. 2017. PMID: 28182255. doi:10.1111/bjd.15375

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。